Epigenetic Regulators Modulate Muscle Damage in Duchenne Muscular Dystrophy Model

Area of Science:

• Epigenetics
• Molecular Biology
• Muscle Physiology

Background:

• Histone acetyl transferases (HATs) and histone deacetylases (HDACs) regulate gene transcription crucial for muscle development.
• HDAC inhibitors are known to aid muscle regeneration in muscular dystrophy by upregulating follistatin.
• The therapeutic potential of directly targeting HATs in muscular dystrophy has not been explored.

Purpose of the Study:

• To investigate the role of HATs, specifically CBP/p300, in a zebrafish model of Duchenne muscular dystrophy.
• To explore the potential of modulating HAT activity as a therapeutic strategy for preventing early muscle damage.

Main Methods:

• Utilized a zebrafish model of Duchenne muscular dystrophy.
• Analyzed CBP/p300 transcript levels in dystrophin-null embryos.
• Administered CBP overexpression and a pan-HDAC inhibitor (trichostatin A) to assess their effects on muscle damage.
• Investigated the necessity of the HAT domain of CBP for its protective effects.

Main Results:

• CBP/p300 transcripts were downregulated in dystrophin-deficient zebrafish embryos.
• Overexpression of CBP significantly prevented early muscle damage in dystrophin-null embryos.
• The HAT activity of CBP was essential for its muscle-protective function.
• Both CBP and trichostatin A protected muscles without altering endogenous CBP/p300 levels or follistatin expression.

Conclusions:

• Direct modulation of HATs, particularly CBP, offers a novel strategy for preventing early muscle damage in muscular dystrophy.
• This protective mechanism appears independent of known HDAC inhibitor actions related to regeneration.
• Epigenetic regulators like HATs may influence muscular dystrophy severity by enhancing muscle fiber resistance to damage.